Costs of Type 2 Diabetes Treatment in Phukhieo Chalermprakiat Hospital
Article Sidebar
Main Article Content
Abstract
Introduction: The objective of this study is to determine cost of treatment for type 2 diabetes mellitus (T2DM) in healthcare providerzs perspective. Methods: Data of T2DM patients aged 35 years or above who received the treatment in Phukhieo Chalermphrakiat hospital during 1 October 2014 R 30 September 2015 were retrospectively collected from electronic database. This study measured direct medical costs occurred at out-patient (OP) and in-patient (IP) departments including medical service, drug, laboratory test, and medical material costs. Healthcare utilization and costs were described across T2DM patient groups. Results: In fiscal year 2015, there were 4,413 T2DM patients. Most of them were female (69.4%), aged 60.6±10.5 years, without complication (65.1%). Among 4,288 out-patients, average OP visit was 3.8 times/out-patient/year, and among 784 in- patients, average IP visit and length of stay were 1.3 times/in-patient/year and 13.6 days/in-patient/year. Total cost of T2DM treatment was 29,315,121 baht (63.2% OP cost and 36.8% IP cost). Average OP cost was 4,321.0 baht/out-patient/year (77.4% accounted for drug cost) and average IP cost was 13,758.7 baht/in-patient/year (48.9% accounted for medical service cost). For the patients without complication, OP cost was 2,862.3±2,619.0 (median 2,312.2) baht/out-patient/year and IP cost was 9,202.4±14,332.1 (median 4,236.0) baht/in-patient/year. For the patients with complication, OP cost was 6,306.0±9,013.7 (median 4,741.0) baht/in-patient/year and IP cost was 15,609.1±26,255.1 (median 6,999.0) baht/in-patient/year. These costs were the highest in the patients with both micro and macrovascular complications. Conclusion: Treatment of T2DM is costly in particular patients with complication. Effective prevention and control of diabetes and its complication would reduce health burden and expenditure.
Article Details
In the case that some parts are used by others The author must Confirm that obtaining permission to use some of the original authors. And must attach evidence That the permission has been included
References
Burden of Disease Thailand. 2009. Report of Burden of Disease in Thailand B.E.2552. http://www.thaibod.net/th/report/category/6--2009-.htmldownload=37%3A-disability-adjusted-life-year-daly. Accessed August 3, 2015
Chaiyasong S, Rattanachotphanit R, Waleekhachonloet O, Sitthithanyakit B. Cost-Effectiveness of Alendronate and Risedronate for Primary Prevention of Fractures in Postmenopausal Women. IJPS. 2013; 9(2): 23-36.
Chatterjee S, Riewpaiboon A, Piyauthakit P, et al. Cost of diabetes and its complications in Thailand: a complete picture of economic burden. Health Soc Care Community 2011; 19(3): 289-98.
Chumnui S. Factor of Blood Sugar Level Control in Diabetic Patient Type 2 Rongkam Hospital Rongkam District Kalasin Province. Research And Development Health System Journal 2008; 1(3): 60-9.
Herman WH. The cost-effectiveness of diabetes prevention: results from the Diabetes Prevention Program and the Diabetes Prevention Program Outcomes Study Clinical Diabetes and Endocrinology. 20151:9 DOI: 10.1186/s40842-015-0009-1.
Institute of Health Metrics and Evaluation. 2014. Global Burden of Disease.
www.healthdata.org. Accessed Sep 5, 2015.
Javanbakht M, Baradaran HR, Mashayekhi A, et al. Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in Iran. PLoSONE 2011;6(10):e26864. doi: 10.1371/journal.pone.0026864
Kanglee K. Factors Associated With Glycemic Control Among People With Type 2 Diabetes Millitus at Phramongkutklao Hospital, Bangkok. Journal of Royal Thai Army Nurses 2014; 15(3): 256-68.
Li R, Zhang P, Barker LE, Chowdhury FM, Zhang X. Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review. Diabetes Care. 2010 Aug; 33(8): 1872-1894.
Phukhieo Chalermprakiat hospital. Hospital profile 2015.
Phuribancha P, Prompakdee B, Sulakan P. The Cost Effective Analysis of lifestyle Modification and Medication intervention to prevent the development of type 2 diabetes in prediabetes. Journal of Office of Disease Prevention and Control 6 Khon Kaen. 2012; 19(2): 1-16.
Reiwpaiboon A, Chatterjee S, Piyauthakit P. Cost analysis for efficient management: diabetes treatment at a public district hospital in Thailand. Int J Pharm Pract 2011; 5: 342-9.
Tantivipanuwong S. Determination of factors affecting medical expenditures of diabetes patients from electronic database (Master Thesis in Pharmacy Administration). Faculty of Graduate studies. Bangkok: Mahidol University; 2005.
World Health Organization. Global status report on noncommunicable diseases 2010. Geneva:
World Health Organization. 2011.
World Health Organization. Global action plan for the prevention and control of NCDs 2013- 2020. Geneva: World Health Organization. 2013.